FindTrial
Sign In

Levonorgestrel Intrauterine slow-release system clinical research for the treatment of Endometrial hyperplasis.

Levonorgestrel Intrauterine slow-release system clinical research for the treatment of Endometrial hyperplasis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOC-16008297
Enrollment
Unknown
Registered
2016-04-17
Start date
2016-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial hyperplasia

Interventions

experimental group:intrauterine birth control system in the patients.
the control group :Medroxyprogesterone

Sponsors

Second Affiliated Hospital Soochow University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnostic curettage of the pathological diagnosis of endometrial hyperplasia; 2. Patients with no fertility requirements during the period of treatment.

Exclusion criteria

Exclusion criteria: 1. Known or suspected pregancy; 2. With previous pelvic inflammatory disease or pelvic inflammatory disease recurrence; 3. Lower genital tract infection; 4. Postpartum endometritis; 5. Infectious abortion in the past three months; 6. Cervicitis; 7. The cervical dysplasia; 8. The cervical malignant lesions; 9. Hormone-dependent tumor; 10. Abnormal uterine bleeding; 11. Congenital or acquired uterine anomalies; 12. Acute liver disease or liver cancer; 13. Allergic to active ingredients allergy or accessories.

Design outcomes

Primary

MeasureTime frame
Endometrial pathological types;—

Secondary

MeasureTime frame
Endometrial thickness;—

Countries

China

Contacts

Public ContactZhu Weipei

Second Affiliated Hospital Soochow University

zwp333xx@126.com+86 13862012168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026